Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
13.79
+0.11 (0.80%)
Aug 1, 2025, 4:00 PM - Market closed
Bally's Market Cap
Elanco Animal Health has a market cap or net worth of $6.85 billion as of August 1, 2025. Its market cap has increased by 6.20% in one year.
Market Cap
6.85B
Enterprise Value
10.76B
1-Year Change
6.20%
Ranking
Category
Stock Price
$13.79
Market Cap Chart
Since September 20, 2018, Elanco Animal Health's market cap has decreased from $12.82B to $6.85B, a decrease of -46.59%. That is a compound annual growth rate of -8.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 6.85B | 14.40% |
| Dec 31, 2024 | 5.99B | -18.47% |
| Dec 29, 2023 | 7.34B | 26.71% |
| Dec 30, 2022 | 5.79B | -56.84% |
| Dec 31, 2021 | 13.43B | -7.23% |
| Dec 31, 2020 | 14.47B | 31.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |